Phibro Animal Health CFO granted 3,334 RSUs

David Glenn reported acquisition or exercise transactions in this Form 4 filing.

The filer has since corrected this document, so the figures below are the ones originally reported and some of them may have changed. Read the amended Form 4/A for what the company says now.

Rhea-AI Filing Summary

David Glenn reported acquisition or exercise transactions in this Form 4 filing.

PHIBRO ANIMAL HEALTH CORP reported that Chief Financial Officer David Glenn received an award of 3,334 shares of Class A Common Stock in the form of restricted stock units. The award was recorded at a per-share price of $0.00 as a grant, not a market purchase.

The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, contingent on his continued employment through each vesting date. Following this award, Glenn’s directly held Class A Common Stock position is reported as 54,811 shares.

Insider Trade Summary

Grant/Award: 3,334 shares

Grant/Award 1 txn

Insider David Glenn

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1, F2	3,334	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 54,811 shares (Direct)

Footnotes (2)

1. F1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. F2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

Key Figures

RSUs granted: 3,334 shares Price per share for grant: $0.00 per share Shares owned after transaction: 54,811 shares +1 more

4 metrics

RSUs granted 3,334 shares Restricted stock units representing Class A Common Stock granted to CFO David Glenn

Price per share for grant $0.00 per share Grant, award, or other acquisition of RSUs, not a market purchase

Shares owned after transaction 54,811 shares Directly held Class A Common Stock following the RSU grant

Vesting start reference date August 1, 2026 RSUs vest in substantially equal installments on first three anniversaries of this date

Key Terms

restricted stock units, Class A Common Stock, vesting

3 terms

restricted stock units financial

"The reported securities represent restricted stock units ("RSUs"), each of which represents"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"each of which represents a contingent right to receive one share of Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vesting financial

"The RSUs vest in substantially equal installments on each of the first three anniversaries"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PHIBRO ANIMAL HEALTH (PAHC) CFO David Glenn report in this Form 4?

David Glenn reported a grant of 3,334 restricted stock units tied to Class A Common Stock. The grant is a compensation award at $0.00 per share, increasing his reported direct holdings to 54,811 shares after the transaction.

How many PAHC shares were granted to CFO David Glenn in this transaction?

The filing shows a grant of 3,334 RSUs, each representing one share of Class A Common Stock. These units are contingent rights that convert into shares as they vest under the award’s schedule.

What is the vesting schedule for David Glenn’s new PAHC RSU award?

The RSUs vest in three substantially equal installments on each of the first three anniversaries of August 1, 2026. Vesting is subject to continued employment through each applicable vesting date, according to the disclosure.

What are David Glenn’s PAHC share holdings after this Form 4 transaction?

After the reported RSU grant, David Glenn’s direct holding of PAHC Class A Common Stock is 54,811 shares. This figure reflects shares beneficially owned following the compensation-related acquisition reported in the Form 4.

Was the PAHC CFO’s Form 4 transaction a market buy or sale of shares?

No market trade was reported; the Form 4 describes a grant of restricted stock units coded as an acquisition (A). The $0.00 per-share price indicates a compensation award, not an open-market purchase or sale of PAHC stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 04:19 PM Accepted by SEC EDGAR 08/10/2026 - 04:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

David Glenn

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	08/06/2026		A		3,334(2)	A	$0	54,811	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.

2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

	/s/ Judith Weinstein, as Attorney-in-Fact for Glenn David	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)